Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
Open Access
- 1 July 2018
- journal article
- review article
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 81 (3), 187-197
- https://doi.org/10.4046/trd.2018.0030
Abstract
Chronic obstructive pulmonary disease (COPD) is a frequent comorbid condition associated with increased morbidity and mortality. Pneumonia is the most common infectious disease condition. The purpose of this review is to evaluate the impact of pneumonia in patients with COPD. We will evaluate the epidemiology and factors associated with pneumonia. We are discussing the clinical characteristics of COPD that may favor the development of infections conditions such as pneumonia. Over the last 10 years, there is an increased evidence that COPD patients treated with inhaled corticosteroids are at increased risk to develp pneumonia. We will review the avaialbe information as well as the possible mechanism for this events. We also discuss the impact of influenza and pneumococcal vaccination in the prevention of pneumonia in COPD patients.This publication has 98 references indexed in Scilit:
- Inhaled corticosteroids in COPD and the risk of serious pneumoniaThorax, 2013
- Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPDThorax, 2012
- The Lung Tissue Microbiome in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients with PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPDPLOS ONE, 2011
- The InflammasomesCell, 2010
- The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trialRespiratory Research, 2009
- Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespiratory Research, 2009
- MUC5B Is the Major Mucin in the Gel Phase of Sputum in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Respiratory Tract Mucin Genes and Mucin Glycoproteins in Health and DiseasePhysiological Reviews, 2006